Search results
Amy Oppenheimer To Premiere Solo Show LOOKING FOR JUSTICE (IN ALL THE WRONG PLACES) At Capital...
Broadway World· 2 days agoLooking for Justice (in all the wrong places) about her lifelong search for racial and sexual...
7 Classic Biopics About Historical Figures From Abraham Lincoln to Ruth Bader Ginsburg
Deadline via Yahoo News· 10 hours agoLives of historical figures often get cinematic treatment to tell sweeping tales of real life...
Friday's biggest analyst calls: Microsoft price target increase, Lyft gets an upgrade
CNBC· 1 day agoPlease refresh every 20-30 minutes to view the latest posts.) Microsoft and Lyft were among the...
3 underrated movies on Hulu you need to watch in June 2024
Digital Trends via Yahoo News· 15 hours agoWith Lisa by their side, the boys’ popularity skyrockets, putting them on the radar of their...
International Insider: Big Week For ‘Peaky’; Seriencamp Shows German TV’s Mettle; Deals In The...
Deadline Hollywood· 22 hours agoThe show that launched a thousand undercuts and laid the foundations for Cillian Murphy’s ...
Cillian Murphy Irish Drama ‘Small Things Like These’ Lands at Lionsgate
The Hollywood Reporter via Yahoo News· 3 days agoCillian Murphy’s Oppenheimer follow-up, the Irish drama Small Things Like These, has landed at...
6 San Diego scientists elected to National Academy of Sciences, embellishing the region's standing...
U-T San Diego· 14 hours agoSix San Diego researchers have been elected to the National Academy of Sciences, the elite honorary...
Microsoft To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday - Microsoft...
Benzinga· 22 hours agoBig Lots shares dipped 18.2% to close at $2.88 on Thursday. See how other analysts view this stock. ...
Lululemon Athletica Recovering From Merchandising Missteps, Says Analyst - Lululemon Athletica...
Benzinga· 4 days agoOppenheimer analyst Brian Nagel reiterated an Outperform rating on the shares of Lululemon Athletica...
Lyft, 3M upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 20 hours agoThe company reduced Q4 EBITDA guidance to reflect April and May Demand trends, the analyst says. Oppenheimer downgraded Seres Therapeutics (MCRB) to...